Xuewen Tang1, Tingting Tang2, Rui Yan1, Yang Zhou1, Xuan Deng1, Hanqing He1. 1. Department of Immunization Program, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, P.R. China. 2. Department of Immunization Program, Yunnan Provincial Center for Disease Control and Prevention, Kunming, P.R. China.
Abstract
Background: The intention of Chinese people older than age 5 to accept the pertussis vaccination is unknown, which is important for the future design of an effective pertussis vaccination program in China.Method: We conducted a cross-sectional survey among people older than age 5 in China. A 24-item questionnaire was used to explore the determinants of intention to accept a pertussis vaccination, and for children and adolescents (≦15 years old), their guardian was required to help answer the questionnaire on their behalf. Univariate and multivariate logistic regression was used to analyze the influencing factors of intention. Results: A total of 3,041 individuals participated in our survey and 3025 completed the questionnaire, among which 1938 (64.07%) reported a positive intention to be vaccinated. A multiple logistic regression analysis revealed that the main positive factors for the intention to accept pertussis vaccination were younger age (Odd ratio [OR] 0.838, P < .001), higher educational attainment (OR 1.171, P = .002), no hospitalization because of the most recent cough (OR 2.468, P < .001), awareness about pertussis (OR 1.958, P < .001), and consideration of pertussis vaccination to be safe (OR 1.450, P = .026). Conclusion: There is a relatively high level of intention to receive the pertussis vaccine among people older than age 5 in China. Future pertussis vaccination strategies geared at them should consider focusing on middle-aged and older individuals and those with a low education as well as strengthen the promotion of disease characteristics, vaccine effectiveness, and safety.
Background: The intention of Chinese people older than age 5 to accept the pertussis vaccination is unknown, which is important for the future design of an effective pertussis vaccination program in China.Method: We conducted a cross-sectional survey among people older than age 5 in China. A 24-item questionnaire was used to explore the determinants of intention to accept a pertussis vaccination, and for children and adolescents (≦15 years old), their guardian was required to help answer the questionnaire on their behalf. Univariate and multivariate logistic regression was used to analyze the influencing factors of intention. Results: A total of 3,041 individuals participated in our survey and 3025 completed the questionnaire, among which 1938 (64.07%) reported a positive intention to be vaccinated. A multiple logistic regression analysis revealed that the main positive factors for the intention to accept pertussis vaccination were younger age (Odd ratio [OR] 0.838, P < .001), higher educational attainment (OR 1.171, P = .002), no hospitalization because of the most recent cough (OR 2.468, P < .001), awareness about pertussis (OR 1.958, P < .001), and consideration of pertussis vaccination to be safe (OR 1.450, P = .026). Conclusion: There is a relatively high level of intention to receive the pertussis vaccine among people older than age 5 in China. Future pertussis vaccination strategies geared at them should consider focusing on middle-aged and older individuals and those with a low education as well as strengthen the promotion of disease characteristics, vaccine effectiveness, and safety.
Entities:
Keywords:
Pertussis; cross-sectional survey; intention; vaccination program
Authors: Karin Hardt; Paolo Bonanni; Susan King; Jose Ignacio Santos; Mostafa El-Hodhod; Gregory D Zimet; Scott Preiss Journal: Vaccine Date: 2016-11-23 Impact factor: 3.641
Authors: Olga Visser; Janneke Kraan; Reinier Akkermans; Robert A C Ruiter; Koos van der Velden; Jeannine L A Hautvast; Marlies E J L Hulscher Journal: Vaccine Date: 2016-08-11 Impact factor: 3.641
Authors: Domino Determann; Esther W de Bekker-Grob; Jeff French; Helene A Voeten; Jan Hendrik Richardus; Enny Das; Ida J Korfage Journal: Vaccine Date: 2015-12-28 Impact factor: 3.641